MRI as an outcome in multiple sclerosis clinical trials
Citation Manager Formats
Make Comment
See Comments

AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
- MRI as an outcome in multiple sclerosis clinical trials
- Richard B. Tenser, Penn State University College of Medicine, 30 Hope Dr. Hershey, PA 17033rtenser@psu.edu
Submitted June 22, 2009 - Reply from the authors
- Prof. George C. Ebers, University of Oxford, John Radcliffe Hospital Oxford OX39DU, United Kingdomgeorge.ebers@clneuro.ox.ac.uk
- Martin Daumer
Submitted June 22, 2009 - MRI as an outcome in multiple sclerosis clinical trials
- Maria Pia Sormani, Biostatistics Unit, Department of Health Sciences, University of Genoa, Genoa, Italym.filippi@hsr.it
- Massimo Filippi (Neuroimaging Research Unit, Department of Neurology, San Raffaele Scientific Institute, Milan, Italy) and Nicola De Stefano (Quantitative Neuroimaging Lab, Dept. of Neurological & Behavioral Sciences, University of Siena, Siena, Italy)
Submitted May 26, 2009 - Reply from the author
- George Ebers, University of Oxford, Oxford, United KingdomGeorge.Ebers@clneuro.ox.ac.uk
- Martin Daumer,Technical University of Munich, Ludwig Maximilian University and the Sylvia Lawry Centre, Munich, Germany
Submitted May 26, 2009
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.